Endothelial dysfunction, arterial stiffening, and intima-media thickening in large arteries from HIV-1 transgenic mice

Annals of Biomedical Engineering

Volumn 41, Issue 4, 2013, Pages 682-693

  Hansen, Laura ^a   Parker, Ivana ^b   Sutliff, Roy L ^c   Platt, Manu O ^a   Gleason Jr , Rudolph L ^a,b  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Atherosclerosis; HIV; Vascular remodeling

Indexed keywords

ATHEROSCLEROSIS; ATHEROSCLEROTIC LESIONS; CARDIOVASCULAR DISEASE; ENDOTHELIAL DYSFUNCTION; HIGHLY ACTIVE ANTI-RETROVIRAL THERAPIES; HIV; INTIMA-MEDIA THICKNESS; VASCULAR REMODELING;

BIOMECHANICS; MAMMALS; PATIENT TREATMENT; PROTEINS; STIFFNESS;

DISEASES;

HUMAN IMMUNODEFICIENCY VIRUS PROTEIN;

ANIMAL; ARTERIAL STIFFNESS; ARTICLE; ATHEROSCLEROSIS; BIOMEDICAL ENGINEERING; CARDIOVASCULAR DISEASE; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTIMA; MALE; MOUSE; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE; TUNICA MEDIA; VASCULAR ENDOTHELIUM; VIROLOGY; VIRUS GENE; CARDIOVASCULAR DISEASES; COMPLICATION;

ANIMALS; ATHEROSCLEROSIS; BIOMEDICAL ENGINEERING; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; GENES, VIRAL; HIV INFECTIONS; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; MALE; MICE; MICE, TRANSGENIC; TUNICA INTIMA; TUNICA MEDIA; VASCULAR STIFFNESS;

EID: 84876461300     PISSN: 00906964     EISSN: 15739686     Source Type: Journal    
DOI: 10.1007/s10439-012-0702-5     Document Type: Article

References (55)

1. Arnet, D., G. Evans, and W. Riley. Arterial stiffness: a new cardiovascular risk factor? Am. J. Epidemiol. 140:669-682, 1994.
2. Blanco, J. J., I. S. Garcia, J. G. Cerezo, J. M. de Rivera, P. M. Anaya, P. G. Raya, J. G. Garcia, J. R. Lopez, F. J. Hernandez, and J. J. Rodriguez. Endothelial function in HIV-infected patients with low or mild cardiovascular risk. J. Antimicrob. Chemother. 58:133-139, 2006.
3. Bonnet, D., Y. Aggoun, I. Szezepanski, N. Bellal, and S. Blanche. Arterial stiffness and endothelial dysfunction in HIV-infected children. AIDS 18:1037-1041, 2004.
4. Choi, A. I., E. Vittinghoff, S. G. Deeks, C. C. Weekley, Y. Li, and M. G. Shlipak. Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons. AIDS 25:1289-1298, 2011.
5. Chuong, C., and Y. Fung. On residual stress in arteries. J. Biomech. Eng. 108:189-192, 1986.
6. Currier, J. S., A. Taylor, F. Boyd, C. M. Dezii, H. Kawabata, B. Burtcel, J. F. Maa, and S. Hodder. Coronary heart disease in HIV-infected individuals. J. Acquir. Immune Defic. Syndr. 33:506-512, 2003.
7. El-Sadr, W. M., J. D. Lundgren, J. D. Neaton, F. Gordin, D. Abrams, R. C. Arduino, A. Babiker, W. Burman, N. Clumeck, C. J. Cohen, D. Cohn, D. Cooper, J. Darbyshire, S. Emery, G. Fatkenheuer, B. Gazzard, B. Grund, J. Hoy, K. Klingman, M. Losso, N. Markowitz, J. Neuhaus, A. Phillips, and C. Rappoport. CD4+ count-guided interruption of antiretroviral treatment. N. Engl. J. Med. 355:2283-2296, 2006.
8. Fernandez-Moure, J. S., D. Vykoukal, and M. G. Davies. Biology of aortic aneurysms and dissections. Methodist DeBakey Cardiovasc. J. 7:2-7, 2011.
9. Friis-Moller, N., C. A. Sabin, R. Weber, A. d'Arminio Monforte, W. M. El-Sadr, P. Reiss, R. Thiebaut, L. Morfeldt, S. De Wit, C. Pradier, G. Calvo, M. G. Law, O. Kirk, A. N. Phillips, and J. D. Lundgren. Combination antiretroviral therapy and the risk of myocardial infarction. N. Engl. J. Med. 349:1993-2003, 2003.
10. Friis-Moller, N., R. Weber, P. Reiss, R. Thiebaut, O. Kirk, A. d'Arminio Monforte, C. Pradier, L. Morfeldt, S. Mateu, M. Law, W. El-Sadr, S. De Wit, C. A. Sabin, A. N. Phillips, and J. D. Lundgren. Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the DAD study. AIDS 17:1179-1193, 2003.
11. Grubb, J. R., A. Dejam, J. Voell, W. C. Blackwelder, P. A. Sklar, J. A. Kovacs, R. O. Cannon, H. Masur, and M. T. Gladwin. Lopinavir-ritonavir: effects on endothelial cell function in healthy subjects. J. Infect. Dis. 193:1516-1519, 2006.
12. Hsue, P. Y., P. W. Hunt, A. Schnell, S. C. Kalapus, R. Hoh, P. Ganz, J. N. Martin, and S. G. Deeks. Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. AIDS 23:1059-1067, 2009.
13. Hsue, P. Y., P. W. Hunt, Y. Wu, A. Schnell, J. E. Ho, H. Hatano, Y. Xie, J. N. Martin, P. Ganz, and S. G. Deeks. Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients. AIDS 23:2021-2027, 2009.
14. Hsue, P. Y., J. C. Lo, A. Franklin, A. F. Bolger, J. N. Martin, S. G. Deeks, and D. D. Waters. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation 109:1603-1608, 2004.
15. Kadar, A., and T. Glasz. Development of atherosclerosis and plaque biology. Cardiovasc. Surg. 9:109-121, 2001.
16. Kaplan, R. C., L. A. Kingsley, A. R. Sharrett, X. Li, J. Lazar, P. C. Tien, W. J. Mack, M. H. Cohen, L. Jacobson, and S. J. Gange. Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clin. Infect. Dis. 45:1074-1081, 2007.
17. Kaplan, R. C., E. Sinclair, A. L. Landay, N. Lurain, A. R. Sharrett, S. J. Gange, X. Xue, C. M. Parrinello, P. Hunt, S. G. Deeks, and H. N. Hodis. T cell activation predicts carotid artery stiffness among HIV-infected women. Atherosclerosis 217:207-213, 2011.
18. Kline, E. R., and R. L. Sutliff. The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction. J. Investig. Med. 56:752-769, 2008.
19. Kopp, J. B., M. E. Klotman, S. H. Adler, L. A. Bruggeman, P. Dickie, N. J. Marinos, M. Eckhaus, J. L. Bryant, A. L. Notkins, and P. E. Klotman. Progressive glomerulosclerosis and enhanced renal accumulation of basement-membrane components in mice transgenic for human-immunodeficiency-virus type-1 genes. Proc. Natl. Acad. Sci. U.S.A. 89:1577-1581, 1992.
20. Lee, H.-Y., and B.-H. Oh. Aging and arterial stiffness. Circ. J. 74:2257-2262, 2010.
21. Li, W. A., Z. T. Barry, J. D. Cohen, C. L. Wilder, R. J. Deeds, P. M. Keegan, and M. O. Platt. Detection of femtomole quantities of mature cathepsin K with zymography. Anal. Biochem. 401:91-98, 2010.
22. Lorenz, M., C. Stephan, A. Harmjanz, S. Staszewski, A. Buehler, M. Bickel, S. von Kegler, D. Ruhkamp, H. Steinmetz, and M. Sitzer. Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis. Atherosclerosis 196:720-726, 2008.
23. Lundgren, J., J. Neuhaus, A. Babiker, D. Cooper, D. Duprez, W. El-Sadr, S. Emery, F. Gordin, J. Kowalska, A. Phillips, R. Prineas, P. Reiss, C. Sabin, R. Tracy, R. Weber, B. Grund, and J. Neaton. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients. AIDS 22:F17-F24, 2008.
24. Lutgens, E., S. P. Lutgens, B. C. Faber, S. Heeneman, M. M. Gijbels, M. P. de Winther, P. Frederik, I. van der Made, A. Daugherty, A. M. Sijbers, A. Fisher, C. J. Long, P. Saftig, D. Black, M. J. Daemen, and K. B. Cleutjens. Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation. Circulation 113:98-107, 2006.
25. Maggi, P., A. Lillo, F. Perilli, R. Maserati, and A. Chirianni. Colour-Doppler ultrasonography of carotid vessels in patients treated with antiretroviral therapy: a comparative study. AIDS 18:1023-1028, 2004.
26. Mary-Krause, M., L. Cotte, A. Simon, M. Partisani, and D. Costagliola. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS 17:2479-2486, 2003.
27. Matzen, K., A. E. M. Dirkx, M. G. A. oude Egbrink, C. Speth, M. Götte, G. Ascherl, T. Grimm, A. W. Griffioen, and M. Stürzl. HIV-1 Tat increases the adhesion of monocytes and T-cells to the endothelium in vitro and in vivo: implications for AIDS-associated vasculopathy. Virus Res. 104:145-155, 2004.
28. McComsey, G. A., M. O'Riordan, S. L. Hazen, D. El-Bejjani, S. Bhatt, M. L. Brennan, N. Storer, J. Adell, D. A. Nakamoto, and V. Dogra. Increased carotid intima media thickness and cardiac biomarkers in HIV infected children. AIDS 21:921-927, 2007.
29. Meng, Q., J. A. Lima, H. Lai, D. Vlahov, D. D. Celentano, S. A. Strathdee, K. E. Nelson, K. C. Wu, S. Chen, W. Tong, and S. Lai. Coronary artery calcification, atherogenic lipid changes, and increased erythrocyte volume in black injection drug users infected with human immunodeficiency virus-1 treated with protease inhibitors. Am. Heart J. 144:642-648, 2002.
30. Mercie, P., R. Thiebaut, V. Aurillac-Lavignolle, J. L. Pellegrin, M. C. Yvorra-Vives, C. Cipriano, D. Neau, P. Morlat, J. M. Ragnaud, M. Dupon, F. Bonnet, S. Lawson-Ayayi, D. Malvy, R. Roudaut, and F. Dabis. Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients. HIV Med. 6:380-387, 2005.
31. Oliviero, U., G. Bonadies, V. Apuzzi, M. Foggia, G. Bosso, S. Nappa, A. Valvano, E. Leonardi, G. Borgia, G. Castello, R. Napoli, and L. Sacca. Human immunodeficiency virus per se exerts atherogenic effects. Atherosclerosis 204:586-589, 2009.
32. Paladugu, R., W. P. Fu, B. S. Conklin, P. H. Lin, A. B. Lumsden, Q. Z. Yao, and C. Y. Chen. HIV Tat protein causes endothelial dysfunction in porcine coronary arteries. J. Vasc. Surg. 38:549-555, 2003.
33. Park, I.-W., J.-F. Wang, and J. E. Groopman. HIV-1 tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes. Blood 97:352-358, 2001.
34. Platt, M. O., R. F. Ankeny, G. P. Shi, D. Weiss, J. D. Vega, W. R. Taylor, and H. Jo. Expression of cathepsin K is regulated by shear stress in cultured endothelial cells and is increased in endothelium in human atherosclerosis. Am. J. Physiol. Heart Circ. Physiol. 292:H1479-H1486, 2007.
35. Seaberg, E. C., L. Benning, A. R. Sharrett, J. M. Lazar, H. N. Hodis, W. J. Mack, M. J. Siedner, J. P. Phair, L. A. Kingsley, and R. C. Kaplan. Association between human immunodeficiency virus infection and stiffness of the common carotid artery. Stroke 41:2163-2170, 2010.
36. Sevastianova, K., J. Sutinen, J. Westerbacka, M. Ristola, and H. Yki-Jarvinen. Arterial stiffness in HIV-infected patients receiving highly active antiretroviral therapy. Antivir. Ther. 10:925-935, 2005.
37. Shankar, S. S., M. P. Dube, J. C. Gorski, J. E. Klaunig, and H. O. Steinberg. Indinavir impairs endothelial function in healthy HIV-negative men. Am. Heart J. 150:933, 2005.
38. Stein, J. H., M. A. Klein, J. L. Bellehumeur, P. E. McBride, D. A. Wiebe, J. D. Otvos, and J. M. Sosman. Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation 104:257-262, 2001.
39. Sukhova, G. K., G. P. Shi, D. I. Simon, H. A. Chapman, and P. Libby. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J. Clin. Invest. 102:576-583, 1998.
40. Sukhova, G. K., Y. Zhang, J. H. Pan, Y. Wada, T. Yamamoto, M. Naito, T. Kodama, S. Tsimikas, J. L. Witztum, M. L. Lu, Y. Sakara, M. T. Chin, P. Libby, and G. P. Shi. Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J. Clin. Invest. 111:897-906, 2003.
41. Sutliff, R. L., S. Dikalov, D. Weiss, J. Parker, S. Raidel, A. K. Racine, R. Russ, C. P. Haase, W. R. Taylor, and W. Lewis. Nucleoside reverse transcriptase inhibitors impair endothelium-dependent relaxation by increasing superoxide. Am. J. Physiol. Heart Circ. Physiol. 283:H2363-H2370, 2002.
42. Sutliff, R. L., C. S. Weber, J. Qian, M. L. Miller, T. L. Clemens, and R. J. Paul. Vasorelaxant properties of parathyroid hormone-related protein in the mouse: evidence for endothelium involvement independent of nitric oxide formation. Endocrinology 140:2077-2083, 1999.
43. Teixeira, H. N., E. T. Mesquita, M. L. Ribeiro, A. R. Bazin, C. T. Mesquita, M. P. Teixeira, C. Pellegrini Rda, and A. C. Nobrega. Study of vascular reactivity in HIV patients whether or not receiving protease inhibitor. Arq. Bras. Cardiol. 93:367-373, 2009; (360-366).
44. Timmins, L. H., Q. F. Wu, A. T. Yeh, J. E. Moore, and S. E. Greenwald. Structural inhomogeneity and fiber orientation in the inner arterial media. Am. J. Physiol. Heart Circ. Physiol. 298:H1537-H1545, 2010.
45. Torriani, F. J., L. Komarow, R. A. Parker, B. R. Cotter, J. S. Currier, M. P. Dube, C. J. Fichtenbaum, M. Gerschenson, C. K. Mitchell, R. L. Murphy, K. Squires, and J. H. Stein. Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: the ACTG (AIDS Clinical Trials Group) Study 5152s. J. Am. Coll. Cardiol. 52:569-576, 2008.
46. USAID, 2008 Report on the global AIDS epidemic, 2008.
47. van Vonderen, M. G. A., E. A. M. Hassink, M. A. van Agtmael, C. D. A. Stehouwer, S. A. Danner, P. Reiss, and Y. Smulders. Increase in carotid artery intima-media thickness and arterial stiffness but improvement in several markers of endothelial function after initiation of antiretroviral therapy. J. Infect. Dis. 199:1186-1194, 2009.
48. van Vonderen, M. G. A., Y. M. Smulders, C. D. A. Stehouwer, S. A. Danner, C. M. Gundy, F. Vos, P. Reiss, and M. A. van Agtmael. Carotid intima-media thickness and arterial stiffness in HIV-infected patients: the role of HIV, antiretroviral therapy, and lipodystrophy. J. Acquir. Immune Defic. Syndr. 50:153-161, 2009.
49. van Wijk, J. P., E. J. de Koning, M. C. Cabezas, J. Joven, J. op't Roodt, T. J. Rabelink, and A. M. Hoepelman. Functional and structural markers of atherosclerosis in human immunodeficiency virus-infected patients. J. Am. Coll. Cardiol. 47:1117-1123, 2006.
50. Wagenseil, J. E., N. L. Nerurkar, R. H. Knutsen, R. J. Okamoto, D. Y. Li, and R. P. Mecham. Effects of elastin haploinsufficiency on the mechanical behavior of mouse arteries. Am. J. Physiol. Heart Circ. Physiol. 289:H1209-H1217, 2005.
51. Wan, W., J. B. Dixon, and R. L. Gleason. Constitutive modeling of mouse carotid arteries using experimentally measured microstructural parameters. Biophys. J. 102:2916-2925, 2012.
52. Wan, W., H. Yanagisawa, and R. Gleason. Biomechanical and microstructural properties of common carotid arteries from Fibulin-5 null mice. Ann. Biomed. Eng. 38:3605-3617, 2010.
53. Wilder, C. L., and M. O. Platt. Manipulating substrate and pH in zymography protocols selectively identifies cathepsins K, L, S, and V activity in cells and tissues, 2011 (in review).
54. Worm, S. W., C. Sabin, R. Weber, P. Reiss, W. El-Sadr, F. Dabis, S. De Wit, M. Law, A. D. Monforte, N. Friis-Moller, O. Kirk, E. Fontas, I. Weller, A. Phillips, and J. Lundgren. Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study. J. Infect. Dis. 201:318-330, 2010.
55. Zoumi, A., X. A. Lu, G. S. Kassab, and B. J. Tromberg. Imaging coronary artery microstructure using second-harmonic and two-photon fluorescence microscopy. Biophys. J. 87:2778-2786, 2004.